SRT-2172

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameSRT-2172
Drug Alias NameNAD-dependent deacetylase sirtuin-1 stimulator/MMP9 gene inhibitor (Sirtris Pharmaceuticals)SRT-2172
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMatrix metalloproteinase 9 inhibitorsNAD-dependent deacetylase sirtuin 1 stimulants
TargetsMatrix metalloproteinase 9NAD-dependent deacetylase sirtuin 1
Therapy Area/IndicationsPulmonary Disease, Chronic Obstructive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSirtris Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSirtris Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsPulmonary Disease, Chronic Obstructive

Other Information

ATC CodeN/A
Related LinksN/A